Biomarkers and the Utility of Proteomics for Dose Optimization and Confirmation of Target Engagement
Sep 30, 2022 ·
41m 36s
In this inaugural episode, Dr. Gately sits down with Dr. Emanuel “Chip” Petricoin, professor at George Mason University in the School of Systems Biology, Co-Director of the Center for Applied...
show more
In this inaugural episode, Dr. Gately sits down with Dr. Emanuel “Chip” Petricoin, professor at George Mason University in the School of Systems Biology, Co-Director of the Center for Applied Proteomics and Molecular Medicine and founder and chairman of the scientific advisory board at Theralink Technologies. The two delve into a deep discussion on the development of Reverse Phase Protein Array technology, the importance of next-generation sequencing in partnership with proteomic analyses, and much more.
show less
Information
| Author | Industry Dive's studioID |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
